| ||||||||||||||
|
|
|||||||||||||
From the Department of Anesthesiology, Buddhist Tzu-Chi Medical Center, Tzu-Chi University School of Medicine, Hualien, Taiwan
Address correspondence to Ming-Hwang Shyr, MD, PhD, Department of Anesthesiology, Buddhist Tzu-chi Medical Center, Tzu-chi University School of Medicine, No. 707, Sec 3, Chung-Yang Road, Hualien, 970, Taiwan. Address reprint requests to Yi Lee, MD, Department of Anesthesiology, Tzu-Chi Medical Center, Tzu-Chi University School of Medicine, no. 707, Sec 3, Chung-Yang Road, Hualien, Taiwan, ROC. Address e-mail to dr.stone{at}msa.hinet.net or drleeyi@sinamail.com.
We designed this study to determine the minimum dose of dexamethasone for preventing nausea and vomiting associated with the use of morphine by patient-controlled analgesia (PCA). Two hundred forty female patients were randomly assigned to receive dexamethasone 2, 4, 8, or 12 mg IV immediately before induction of anesthesia. Droperidol (0.1 mg/mL with morphine 1 mg/mL in PCA pump) and saline were used as controls. The complete response (no postoperative nausea and vomiting and no need for rescue antiemetic for a 24-h postoperative period) rates for dexamethasone 8 mg (72.2%) and 12 mg (78.9%) were significantly more than for saline (42.9%) (P < 0.05). Patients who received dexamethasone 12 or 8 mg also reported higher patient satisfaction than those who received saline (P < 0.05). These results were as effective as adding droperidol 0.1 mg/mL to the morphine PCA without causing drowsiness, restlessness, or arrhythmias. Smaller doses of dexamethasone (4 or 2 mg) were not effective for this propose. The results suggest that dexamethasone 8 mg IV is the minimum effective dose for the reduction of PCA morphine-related nausea and vomiting.
IMPLICATIONS: Morphine administration by patient-controlled analgesia (PCA) is often associated nausea and vomiting. In this double-blind study, the minimum effective dose of dexamethasone for reducing this complication was 8 mg. This was as effective as adding droperidol 0.1 mg/mL to the morphine PCA without causing drowsiness, restlessness or arrhythmias.
This article has been cited by other articles:
![]() |
M. J. Paech, M. W.M. Rucklidge, J. Lain, P. H. Dodd, E.-J. Bennett, and D. A. Doherty Ondansetron and Dexamethasone Dose Combinations for Prophylaxis Against Postoperative Nausea and Vomiting Anesth. Analg., April 1, 2007; 104(4): 808 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hans, A. Vanthuyne, P. Y. Dewandre, J. F. Brichant, and V. Bonhomme Blood glucose concentration profile after 10 mg dexamethasone in non-diabetic and type 2 diabetic patients undergoing abdominal surgery Br. J. Anaesth., August 1, 2006; 97(2): 164 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Grass Patient-Controlled Analgesia Anesth. Analg., November 1, 2005; 101(5S_Suppl): S44 - 61. [Abstract] [Full Text] [PDF] |
||||
|